PCSK9 inhibition across a wide spectrum of patients: One size fits all?

Media formats available:

PCSK9 inhibition & CV events: Review of recent and upcoming hard endpoint outcome trials
PCSK9 inhibition & CV events: Review of recent and upcoming hard endpoint outcome trials
PCSK9 Inhibition & CV Outcomes: Review of Lipid Targets and Treatment Strategies
PCSK9 inhibition & CV events: Review of recent and upcoming hard endpoint outcome trials
- Peter Sever, MD
Understanding new PCSK9 outcome data: From the LDL-C hypothesis to LDL-c causality
Understanding new PCSK9 outcome data: From the LDL-C hypothesis to LDL-c causality
PCSK9 Inhibition & CV Outcomes: Review of Lipid Targets and Treatment Strategies
Understanding new PCSK9 outcome data: From the LDL-C hypothesis to LDL-c causality
- John Chapman

PACE-CME